Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype
Open Access
- 21 March 2011
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 86 (7), 579-585
- https://doi.org/10.1002/ajh.22035
Abstract
Juvenile Myelomonocytic Leukemia (JMML) is a relentlessly progressive myeloproliferative/myelodysplastic (MPD/MDS) hematopoietic disorder more common in patients with any one of at least three distinct genetic lesions, specifically NF1 gene loss and PTPN11 and NRAS mutations. NF1 and PTPN11 are molecular lesions associated with Neurofibromatosis Syndrome Type I (NF1 Syndrome) and Noonan's Syndrome, respectively. The occurrence of JMML is rare; even among those predisposed with these syndromes to development of disease, and secondary genetic events likely contribute to the development and progression of disease. In NF1 syndrome, loss of p53 function is a common event in solid tumors, but uncommon in JMML, suggesting that the p53 pathway may be modified by other events in this hematopoietic disorder. The work presented here investigates the possible role of the p19 Arf (p19 ) tumor suppressor in development of MPD associated with Nf1 gene loss in mice. We find that Nf1 mutant hematopoietic cells with loss of p19 develop accelerated hematopoietic disease similar to acute leukemia with a variable phenotype. This suggests that p19 may play a role in development of JMML and evaluation of the human p19 homolog (p14 ARF ) in JMML may be informative. Am. J. Hematol. 86:579–585, 2011.Keywords
This publication has 40 references indexed in Scilit:
- p14ARF, p15INK4band p16INK4aMethylation Status in Chronic Myelogenous LeukemiaLeukemia & Lymphoma, 2004
- Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorderBlood, 2004
- Expression of the p14ARF tumor suppressor predicts survival in acute myeloid leukemiaLeukemia, 2004
- Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activationHuman Mutation, 2004
- Tumor suppressor genes in normal and malignant hematopoiesisOncogene, 2002
- Modeling myeloid leukemia tumor suppressor gene inactivation in the mouseSeminars in Cancer Biology, 2001
- Flt3 ligand induces the outgrowth of Mac-1+B220+ mouse bone marrow progenitor cells restricted to macrophage differentiation that coexpress early B cell–associated genesExperimental Hematology, 1999
- Inducible Gene Targeting in MiceScience, 1995
- Analysis of mutations of neurofibromatosis type 1 gene and N‐ ras gene in acute myelogenous leukemiaThe International Journal of Cell Cloning, 1995
- Neurofibromatosis and childhood leukemiaThe Journal of Pediatrics, 1978